wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1
Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy.
P2860
Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4612c6c99cb26e4c63be69d2a4a153bdff7ac6a5
P2860
Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells